Vaccines

Jun 28, 2017
By Pharmaceutical Technology Editors
Two recently-signed agreements will transfer Takeda’s measles and acellular pertussis vaccine technologies to India-based multinational company Biological E. Limited to develop low-cost combination vaccines including diphtheria, tetanus and acellular pertussis (DTaP), and measles-rubella (MR) vaccines.
Jun 28, 2017
By Pharmaceutical Technology Editors
The directorate highlights its 2016 achievements.
Jun 22, 2017
By Pharmaceutical Technology Editors
A loan from the European Investment Bank will give BiondVax resources for Phase III trials and a manufacturing facility for its universal flu vaccine.
Apr 12, 2017
By Pharmaceutical Technology Editors
The agency issued its recommendation for the influenza virus strains European vaccine manufacturers should include for 2017.
Apr 11, 2017
By Pharmaceutical Technology Editors
In a new study, researchers from Boston Children’s Hospital study responses to pneumococcal vaccine in infant monkeys.
Jan 09, 2017
The partnership will focus on providing practical information to clients on the development of biologics and vaccines.
Dec 16, 2016
By Pharmaceutical Technology Editors
Univercells received a grant from the Bill & Melinda Gates Foundation for the development of a vaccine manufacturing platform.
Dec 15, 2016
By Pharmaceutical Technology Editors
GlaxoSmithKline opened a new vaccines R&D center in Rockville, MD creating up to 200 new jobs.
Nov 30, 2016
By Pharmaceutical Technology Editors
Takeda will invest more than 100 million Euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany.
Nov 17, 2016
By Pharmaceutical Technology Editors
Research by agency scientists may help speed development of Zika virus vaccines.
native1_300x100
lorem ipsum